Clinical Features of Oral Candidiasis Among Patients Visiting the Dental Clinics in College of Dentistry, University of Hilla, Babylon, Iraq

Main Article Content

Abdulridha T. Sarhan
Ahmed B. Mekkin
Ameer S. Turki
Ali A. AL-karrem

Abstract

The most prevalent illness in the oral cavity and in general dentistry practice is oral candidiasis, often known as thrush, which can afflict anyone. Candida albicans, which is typically present in the mouths of approximately 50% of the global population as a normal component of the oral microbiota but during host immunosuppression or alterations in oral microbiota, is the most frequently implicated organism in this condition. It is a fungal infection caused by Candida spp.


If the conditions within the mouth alter in a way that promotes the growth of Candida albicans, the organism may proliferate and result in an infection. Additional variables that may contribute to this oral infection include dentures, diabetes, cancer, mucosal disorders, and some pharmacological therapies. Although the fungus that causes candidiasis cannot be passed from person to person, it can be through an infected person's saliva. The symptoms, which include elevated patches in the mouth that bleed and become sore when scraped, as well as white or yellow spots in the mouth, especially on the tongue and inside of the cheeks, are usually simple to see. It is present in many healthy individuals and settles in the mucous membrane of the oral cavity. The general consensus is that there are six recognized clinical manifestations of candidiasis: pseudomembranous, erythematous, denture-associated, hyperplastic, angular cheilitis, and median rhomboid glossitis. Patients with the condition typically exhibit a single distinct type, though occasionally a single patient may exhibit multiple clinical variants. Patients who visited the dentistry department's clinics at Hilla University College in Babylon, Iraq between October 2022 and April 2023 provided the data.

Article Details

How to Cite
Abdulridha T. Sarhan, Ahmed B. Mekkin, Ameer S. Turki, & Ali A. AL-karrem. (2024). Clinical Features of Oral Candidiasis Among Patients Visiting the Dental Clinics in College of Dentistry, University of Hilla, Babylon, Iraq. International Journal of Pharmaceutical and Bio Medical Science, 4(10), 789–793. https://doi.org/10.47191/ijpbms/v4-i10-03
Section
Articles

References

I. Manoela D. M., Felipe P. F., João F. S. et al. Oral Candidiasis. Clinical Decision-Making in Oral Medicine. First On-line: pp 2023; 73–80. https://link.springer.com/chapter/10.1007/978-3-031-14945-0_11

II. Hu L, He C, Zhao C, Chen X, Hua H, Yan Z. Characterization of oral candidiasis and the Candida species profile in patients with oral mucosal diseases. Microb Pathog. 2019; 134:103575. https://doi.org/10.1016/j.micpath.2019.103575

III. Belazi M, Velegraki A, Koussidou-Eremondi T, et al. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment. Oral Microbiol Immunol 2004; 19:347– 351. https://doi.org/10.1111/J.1399-302X.2004.00165.X

IV. Xiao J, Xu G, de Hoog S, Qiao J, Fang H, Li Y. Oral prevalence of Candida species in patients undergoing systemic glucocorticoid therapy and the antifungal sensitivity of the isolates. Infect Drug Resist. 2020; 13:2601–2607.

https://doi.org/10.2147/IDR.S262311

V. Belazi M, Velegraki A, Fleva A, et al. Candidal overgrowth in diabetic patients: potential predisposing factors. Mycoses 2005; 48:192–196. https://doi.org/10.1111/j.1439-0507.2005.01124.x

VI. Maheronnaghsh M, Fatahinia M, Dehghan P, Teimoori A. Identification of Candida species and antifungal susceptibility in cancer patients with oral lesions in Ahvaz, Southern West of Iran. Adv Biomed Res. 2020; 9:50.

https://doi.org/10.4103/abr.abr_214_19

VII. Jiuyan Q., Milena P R., Karolyne G C. et al. Candida-associated denture stomatitis: clinical, epidemiological, and microbiological features. Braz J Microbiol. 2023; 54(2): 841-848.

https://pubmed.ncbi.nlm.nih.gov/36940013

VIII. Gabriela A., Rani I., Marcos A. et al. Persistent erythematous candidiasis as a sequela after SARS-CoV-2 infection: A case report. Oral Surgery 2023; 16(2): 237-239. https://doi.org/10.1111/ors.12777

IX. Taissa V., Ahmed S. S., Ahmed S. S.,Daniel M –J, and Mary A. J-R. Oral Candidiasis: A Disease of Opportunity. J. Fungi 2020; 6(1), 15.

https://doi.org/10.3390/jof6010015

X. Gow NAR, Yadav B. Microbe Profile: Candida albicans: a shape-changing, opportunistic pathogenic fungus of humans. Microbiology (Reading). 2017; 163(8):1145-1147.

https://doi.org/10.1099/mic.0.000499

XI. Alessandra F., Maria C., Vitoria, S. An Unconventional Oral Candidiasis in an Immunocompetent Patients. J. Fungi 2023; 9(3), 295. https://doi.org/10.3390/jof9030295

XII. Leung KCN, McMillan AS, Cheung BPK, Leung WK. Sjogren’s syndrome sufferers have increased oral yeast levels despite regular dental care. Oral Dis 2008;14:163–173.

https://pubmed.ncbi.nlm.nih.gov/18302677/

XIII. Akram Z, Al-Kheraif AA, Kellesarian SV, Vohra F, Javed F Comparison of oral Candida carriage in water pipe smokers, cigarette smokers, and non-smokers. J Oral Sci. 2018; 60:115–120. https://doi.org/10.2334/josnusd.17-0090

XIV. Tejavathi N., Soniya K., Shamama M. et.al. Oral erythematous candidiasis: A case report. Int J Med Dent Case Rept: 2020; 7(1):1-4.

https://www.researchgate.net/publication/347301645

XV. Baumgardner DJ. Oral Fungal Microbiota: To Thrush and Beyond. J Patient Cent Res Rev. 2019; Fall. 6 (4):252-261.

https://doi.org/10.17294%2F2330-0698.1705

XVI. Alnuaimi AD, Wiesenfeld D, O'Brien-Simpson NM, Reynolds EC, McCullough MJ. Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: a matched case-control study. Oral Oncol. 2015; Feb. 51 (2):139-45.

https://doi.org/10.1016/j.oraloncology.2014.11.008

XVII. Davies AN, Brailsford SR, Beighton D. Oral candidosis in patients with advanced cancer. Oral Oncol 2006; 42:698–702.

https://doi.org/10.1016/j.oraloncology.2005.11.010

XVIII. Sitheeque MA, Samaranayake LP. Chronic hyperplastic candidosis ⁄ candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med 2003; 14:253–267. https://journals.sagepub.com/doi/10.1177/154411130301400403

XIX. Farah CS, Lynch N, McCullough MJ. Oral fungal infections: an update for the general practitioner. Australian Dental Journal 2010; 55:(1 Suppl): 48–54.

https://doi.org/10.1111/j.1834-7819.2010.01198.x

XX. Kulak-Ozkan Y, Kazazoglu E, Arikan A. Oral hygiene habits, denture cleanliness, presence of yeasts and stomatitis in elderly people. J Oral Rehabil 2002;29: 300–304.

https://pubmed.ncbi.nlm.nih.gov/11896849/

XXI. Nelson BL, Thompson L. Median rhomboid glossitis. Ear Nose Throat J 2007; 86:600–601. https://journals.sagepub.com/doi/10.1177/014556130708601006.

XXII. Shimiyan D., Anshuman J., Satyapal Y. et al. Chronic Hyperplastic and Erythematous Candidiasis Induced by Ill-fitting Complete Denture: A Case Report. Journal of Mahatma Gandhi University of Medical Sciences & Technology 2020; 10.5005. https://creativecommons.org/licenses/by-nc-sa/4.0/deed.en

XXIII. Goldman GH, da Silva Ferreira ME, dos Reis Marques E, et al. Evaluation of fluconazole resistance mechanisms in Candida albicans clinical isolates from HIV- infected patients in Brazil. Diagn Microbiol Infect Dis. 2004; 50:25–32.

https://doi.org/10.1016/j.diagmicrobio.2004.04.009.

XXIV. Laura CC., and Yolanda JS. Clinical and microbiological diagnosis of oral candidiasis. J Clin Exp Dent. 2013; 5(5):e279-86.

http://www.medicinaoral.com/odo/indice.htm

XXV. Samiksha A.,Vidya KL.,2 Rahul RB. Diagnosis and Management of Pseudomembranous Candidiasis. Otolaryngol ENT Res 2017; 8(3): 00249.

https://doi.org/10.15406/joentr.2017.08.00249

XXVI. Soysa NS., Ellepola ANB. The impact of cigarette ⁄ tobacco smoking on oral candidosis: an overview. Oral Dis 2005; 11:268– 273.

https://doi.org/10.1111/j.1601-0825.2005.01115.x

XXVII. Grimoud AM, Lodter JP, Marty N., et al. Improved oral hygiene and Candida species colonization level in geriatric patients. Oral Dis 2005; 11:163–169. https://pubmed.ncbi.nlm.nih.gov/15888107/

XXVIII. Juliana CC., Fernanda A., Fernanda GB., et al. Treatment of Oral Candidiasis Using Photodithazine - Mediated Photodynamic Therapy In Vivo. PLoS ONE 11(6): e0156947.

https://doi.org/10.1371/journal.pone.0156947

XXIX. Laszlo I., Richard M. and Wieland M. Candida auris: the most talked about multidrug-resistant emerging fungal pathogen. Microbiology Australia; 2022; 43(4) 173-176.

https://www.publish.csiro.au/ma/MA22057#:~:text=https%3A//doi.org/10.1071/MA22057